HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marco Rovaris Selected Research
Marco Rovaris Research Topics
Disease
47
Multiple Sclerosis
01/2024 - 06/2003
9
Relapsing-Remitting Multiple Sclerosis
10/2023 - 07/2005
4
Chronic Progressive Multiple Sclerosis
05/2024 - 01/2012
4
Atrophy
09/2008 - 01/2003
3
Inflammation (Inflammations)
01/2018 - 07/2013
2
COVID-19
12/2022 - 12/2021
2
Progressive Multifocal Leukoencephalopathy
02/2022 - 01/2017
1
Depressive Disorder (Melancholia)
02/2024
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024
1
Neuroinflammatory Diseases
12/2022
1
Pneumonia (Pneumonitis)
12/2022
1
Sclerosis
12/2022
1
Neoplasms (Cancer)
12/2021
1
Sudden Infant Death (SID)
12/2020
1
Neuralgia (Stump Neuralgia)
01/2019
1
Pain (Aches)
01/2019
1
Mycosis Fungoides
10/2018
1
Pathologic Complete Response
10/2018
1
Disease Susceptibility (Diathesis)
01/2018
1
Epstein-Barr Virus Infections
01/2018
1
Hyperuricemia
01/2018
1
Atrioventricular Block
02/2016
1
Bradycardia
02/2016
1
Chronic Disease (Chronic Diseases)
01/2016
1
Disease Progression
11/2014
1
Cardiotoxicity
05/2013
1
Leukopenia
12/2011
1
Demyelinating Diseases (Demyelinating Disease)
06/2003
1
Dementia (Dementias)
03/2002
1
Vasculitis (Vasculitides)
03/2002
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
03/2002
1
Churg-Strauss Syndrome (Allergic Angiitis)
03/2002
1
Microscopic Polyangiitis
03/2002
1
Cognitive Dysfunction
03/2002
Drug/Important Bio-Agent (IBA)
8
Interferons
IBA
01/2020 - 06/2003
6
Glatiramer Acetate (Copaxone)
FDA Link
11/2016 - 08/2003
5
Natalizumab (Tysabri)
FDA Link
05/2024 - 12/2012
4
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2019 - 02/2016
3
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2013
3
Myelin Basic Protein
IBA
01/2023 - 10/2009
2
Antibodies
IBA
01/2024 - 01/2016
2
nitazoxanide (NTZ)
FDA Link
02/2022 - 12/2020
2
nabiximols (Sativex)
IBA
01/2020 - 01/2017
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2018 - 01/2003
2
Cytokines
IBA
01/2016 - 01/2014
2
Contrast Media
IBA
07/2012 - 09/2008
2
Interferon-beta
IBA
01/2012 - 12/2011
2
N-acetylaspartate (N-acetyl aspartate)
IBA
08/2007 - 06/2005
2
Interferon beta-1a
FDA Link
10/2004 - 01/2003
1
DNA (Deoxyribonucleic Acid)
IBA
01/2024
1
teriflunomide
IBA
10/2023
1
Calcitriol Receptors (Calcitriol Receptor)
IBA
08/2023
1
Purinergic Receptors (Receptors, Purine)
IBA
12/2022
1
Purinergic P2X7 Receptors
IBA
12/2022
1
Oligoclonal Bands
IBA
12/2022
1
Environmental Pollutants (Pollutants, Environmental)
IBA
12/2022
1
Air Pollutants (Pollutants, Air)
IBA
12/2022
1
Solutions
IBA
12/2021
1
Azathioprine (Imuran)
FDA Link
Generic
12/2021
1
Cannabidiol
IBA
01/2020
1
Therapeutic Uses
IBA
01/2020
1
Dronabinol (THC)
FDA Link
Generic
01/2020
1
RNA (Ribonucleic Acid)
IBA
03/2019
1
MicroRNAs (MicroRNA)
IBA
03/2019
1
salicylhydroxamic acid (SHAM)
IBA
01/2019
1
Granzymes (Granzyme)
IBA
10/2018
1
Perforin
IBA
10/2018
1
NLR Proteins
IBA
01/2018
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2018
1
Lipopolysaccharides
IBA
01/2018
1
Proteins (Proteins, Gene)
FDA Link
01/2018
1
Uric Acid (Urate)
IBA
01/2018
1
Interleukin-18 (Interleukin 18)
IBA
01/2018
1
Caspase 8 (Caspase-8)
IBA
01/2018
1
Inflammasomes
IBA
01/2018
1
Enzymes
IBA
06/2017
1
Iron
IBA
01/2017
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
01/2015
1
Toll-Like Receptor 3
IBA
01/2014
1
Poly I-C
IBA
01/2014
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
07/2013
1
Mitoxantrone (Novantrone)
FDA Link
Generic
05/2013
1
ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)
IBA
07/2012
1
Gadolinium
IBA
07/2012
1
ferric oxide (iron oxide)
IBA
07/2012
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
12/2011
1
Interleukin-10 (Interleukin 10)
IBA
10/2009
1
Protons (Proton)
IBA
08/2007
1
Alemtuzumab (Campath)
FDA Link
01/2003
1
Cladribine
FDA Link
Generic
01/2003
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
03/2002
Therapy/Procedure
12
Therapeutics
02/2024 - 01/2003
3
Telerehabilitation
01/2023 - 08/2020
2
Activities of Daily Living (ADL)
04/2019 - 01/2016
2
Meditation
01/2019 - 01/2016
1
Speech Therapy (Therapy, Speech)
01/2023
1
Aftercare (After-Treatment)
01/2019
1
Transcranial Direct Current Stimulation
01/2019
1
Drug Therapy (Chemotherapy)
08/2014
1
Immunomodulation
12/2011